Nationwide Fund Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-12,831
| Closed | -$118K | – | 3367 |
|
|
2017
Q1 | $118K | Sell |
12,831
-1,432
| -10% | -$13.2K | ﹤0.01% | 2794 |
|
|
2016
Q4 | $110K | Buy |
14,263
+1,070
| +8% | +$8.25K | ﹤0.01% | 2845 |
|
|
2016
Q3 | $151K | Sell |
13,193
-20,009
| -60% | -$229K | ﹤0.01% | 2763 |
|
|
2016
Q2 | $409K | Sell |
33,202
-367
| -1% | -$4.52K | ﹤0.01% | 2248 |
|
|
2016
Q1 | $339K | Sell |
33,569
-1,115
| -3% | -$11.3K | ﹤0.01% | 2291 |
|
|
2015
Q4 | $782K | Buy |
34,684
+6
| +0% | +$135 | ﹤0.01% | 1851 |
|
|
2015
Q3 | $575K | Buy |
34,678
+23,745
| +217% | +$394K | ﹤0.01% | 2027 |
|
|
2015
Q2 | $246K | Buy |
10,933
+1,640
| +18% | +$36.9K | ﹤0.01% | 2596 |
|
|
2015
Q1 | $240K | Sell |
9,293
-297
| -3% | -$7.67K | ﹤0.01% | 2605 |
|
|
2014
Q4 | $209K | Sell |
9,590
-134
| -1% | -$2.92K | ﹤0.01% | 2613 |
|
|
2014
Q3 | $184K | Buy |
9,724
+113
| +1% | +$2.14K | ﹤0.01% | 2737 |
|
|
2014
Q2 | $224K | Buy |
9,611
+5,991
| +165% | +$140K | ﹤0.01% | 2696 |
|
|
2014
Q1 | $122K | Hold |
3,620
| – | – | ﹤0.01% | 2686 |
|
|
2013
Q4 | $107K | Sell |
3,620
-4,432
| -55% | -$131K | ﹤0.01% | 2934 |
|
|
2013
Q3 | $123K | Buy |
+8,052
| New | +$123K | ﹤0.01% | 2876 |
|